Clinical Trials Browser

Phase 1/2 × Interventional × MRX-2843 × Clear all

NCT04946890 2021-07-01

A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute